中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 8
Aug.  2016
Turn off MathJax
Article Contents

Several issues regarding evaluation of renal injury and renal insufficiency in patients with liver disease

DOI: 10.3969/j.issn.1001-5256.2016.08.010
  • Received Date: 2016-06-21
  • Published Date: 2016-08-20
  • In patients with liver disease such as viral hepatitis and liver cirrhosis,renal injury and renal insufficiency can be generally classified as acute kidney injury( AKI),chronic kidney disease,and acute- on- chronic nephropathy. AKI can be classified as stage 1( risk stage),stage 2( injury stage),and stage 3( failure stage). Traditionally hepatorenal syndrome is classified as types Ⅰ and Ⅱ,and in recent years,type Ⅲ hepatorenal syndrome with organic renal injury has been proposed. Hepatorenal disorder( HRD) is used to describe any renal disease which occurs in patients with liver cirrhosis. At present,sensitive and accurate biochemical parameters used to evaluate renal function in patients with liver disease in clinical practice include estimated glomerular filtration rate,increase in serum creatinine within unit time,and serum cystatin C level,and urinary microalbumin level also plays an important role in the early diagnosis of nephropathy. Causes of liver disease,severity,complications including infection,nutritional status,therapeutic drugs,and underlying nephropathy may be associated with renal injury and renal insufficiency in patients with liver disease and should be differentiated.

     

  • loading
  • [1]ZHU P,ZHOU FD,ZHAO MH.The renal histopathology spectrum of elderly patients with kidney diseases:a study of 430 patients in a single Chinese center[J].Medicine(Baltimore),2014,93(28):e226.
    [2]YOO JJ,LEE JH,YOON JH,et al.Hepatitis B virus-related glomerulonephritis:not a predominant cause of proteinuria in korean patients with chronic hepatitis B[J].Gastroenterol Res Pract,2015,2015:126532.
    [3]SALERNO F,GERBES A,GINES P,et al.Diagnosis,prevention and treatment of hepatorenal syndrome in cirrhosis[J].Gut,2007,56(9):1310-1318.
    [4]YU YC,WANG MR,HE CL.Recent advances in the diagnosis and treatment of acute kidney injury in patients with liver cirrhosis[J].Infect Dis Info,2014,27(2):69-73.(in Chinese)于乐成,汪茂荣,何长伦.肝硬化急性肾损伤诊治进展[J].传染病信息,2014,27(2):69-73.
    [5]GARCIA-TSAO G.Current management of the complications of cirrhosis and portal hypertension:variceal hemorrhage,ascites,and spontaneous bacterial peritonitis[J].Dig Dis,2016,34(4):382-386.
    [6]YANG Q,SHI YU,YANG Y,et al.Association between adefovir dipivoxil treatment and the risk of renal insufficiency in patients with chronic hepatitis B:a meta-analysis[J].Biomed Rep,2015,3(2):269-275.
    [7]GANE EJ,DERAY G,LIAW YF,et al.Telbivudine improves renal function in patients with chronic hepatitis B[J].Gastroenterology,2014,146(1):138-146.e5.
    [8]NADIM MK,KELLUM JA,DAVENPORT A,et al.Hepatorenal syndrome:the 8th International Consensus Conference of the Acute Dialysis Quality Initiative(ADQI)Group[J].Crit Care,2012,16(1):r23.
    [9]AL-KHAFAJI A,NADIM MK,KELLUM JA.Hepatorenal disorders[J].Chest,2015,148(2):550-558.
    [10]GARCIA-TSAO G,PARIKH CR,VIOLA A.Acute kidney injury in cirrhosis[J].Hepatology,2008,48(6):2064-2077.
    [11]WONG F,NADIM MK,KELLUM JA,et al.Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis[J].Gut,2011,60(5):702-709.
    [12]PERICLEOUS M,SARNOWSKI A,MOORE A,et al.The clinical management of abdominal ascites,spontaneous bacterial peritonitis and hepatorenal syndrome:a review of current guidelines and recommendations[J].Eur J Gastroenterol Hepatol,2016,28(3):e10-e18.
    [13]TRAWALJM,PARADIS V,RAUTOU PE,et al.The spectrum of renal lesions in patients with cirrhosis:a clinicopathological study[J].Liver Int,30(5):725-732.
    [14]FRANCOZ C,DURAND F.A new look at renal dysfunction in the cirrhotic patient[J].Crit Care,2012,16(2):118.
    [15]MURTY MS,SHARMA UK,PANDEY VB,et al.Serum cystatin C as a marker of renal function in detection of early acute kidney injury[J].Indian J Nephrol,2013,23(3):180-183.
    [16]SHLIPAK MG,MATTES M,PERALTA CA,et al.Update on cystatin C:incorporation into clinical practice[J].Am J Kindney Dis,2013,62(3):595-603.
    [17]HEIANZA Y,HARA S,SAITO K,et al.Assessment of kidney dysfunction with cystatin C and creatinine-based estimated glomerular filtration rate and predicting type 2 diabetes:Toranomon Hospital Health Management Center Study 21[J].Diabetes Res Clin Pract,2016,113:60-68.
    [18]SUZUKI Y,MATSUSHITA K,SEIMIYA M,et al.Paradoxical effects of thyroid function on glomerular filtration rate estimated from serum creatinine or standardized cystatin C in patients with Japanese Graves'disease[J].Clin Chim Acta,2015,451(Pt B):316-322.
    [19]INKER LA,SCHMID CH,TIGHIOUART H,et al.Estimating glomerular filtration rate from serum creatinine and cystatin C[J].N Engl J Med,2012,367(1):20-29.
    [20]MINDIKOGLU AL,DOWLING TC,WEIR MR,et al.Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis[J].Hepatology,2014,59(4):1532-1542.
    [21]LIU PP,MA F,LI XC,et al.The value of the urine N-acetylbeta-D-glucosaminidase andβ2-microglobumin in diagnosis of patients with stage 2-4 chronic kidney disease[J].Labeled Immunoassay Clin Med,2015,22(4):262-264.(in Chinese)刘培培,马飞,李兴翠,等.尿N乙酰-β-D氨基葡萄糖苷酶、β2微球蛋白对2至4期慢性肾病患者的临床意义[J].标记免疫分析与临床,2015,22(4):262-264.
    [22]NORDEN AG,LAPSLEY M,UNWIN RJ.Urine retinol-binding protein 4:a functional biomarker of the proximal renal tubule[J].Adv Clin Chem,2014,63:85-122.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2390) PDF downloads(549) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return